Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Cancer Marker |
100T |
| CAT No. |
130203003M |
| Application |
Thyroid Marker |
The kit has been designed for the quantitative determination of Triiodothyronine (T3) in human serum. The method can be used for samples over the range of 0.06-10.0ng/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000, Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
Reliable T3 Testing with Advanced CLIA TechnologyLeverage the power of chemiluminescent immunoassay (CLIA) for the quantitative determination of T3 hormone using the Snibe MAGLUMI T3 kit. The system offers high sensitivity and specificity, making it suitable for routine clinical diagnosis of thyroid disorders. Ready-to-use reagents optimize laboratory workflow and minimize preparation time, providing a seamless experience for laboratory professionals.
Seamless Integration and Efficient UseSnibe MAGLUMI T3 reagents are fully compatible with MAGLUMI series analyzers for automatic, real-time operation. The two-point calibration remains stable for up to 4 weeks, ensuring minimal downtime and consistent results. Each kit comes with all essential components including reagents and calibrators, and performs up to 100 individual tests.
Safe Storage and User ConveniencePackaged in transparent plastic vials with clear labeling, the reagent kit is straightforward to handle and store. With a recommended storage temperature of 2-8C and protection from light, the kit maintains its integrity for a full 12-month shelf life. High purity chemicals assure precise results across the measurement range of 0.30-8.10 nmol/L.
FAQ's of Snibe MAGLUMI T3 (CLIA):
Q: How is the Snibe MAGLUMI T3 (CLIA) reagent kit used in clinical laboratories?
A: The Snibe MAGLUMI T3 (CLIA) kit is used with the MAGLUMI series analyzers for automatic, quantitative measurement of total triiodothyronine (T3) in human serum or plasma. Healthcare professionals follow provided instructions to load samples, reagents, and calibrators for efficient and accurate thyroid function assessment.
Q: What are the required sample types and volumes for this T3 quantification assay?
A: This kit is optimized for use with human serum or plasma samples. The recommended reagent volume per test is specified in the instruction manual, typically ranging from 50 to 100 L per test, ensuring precise measurement for each sample analyzed.
Q: When should calibration be performed and how long does it remain valid?
A: Calibration should be carried out according to the analyzer and kit instructions. This kit supports a two-point calibration that remains stable and valid for up to 4 weeks, allowing consistent and reliable test results over multiple samples.
Q: Where should the Snibe MAGLUMI T3 reagent kit be stored for optimal performance?
A: For best results and prolonged shelf life, store the reagent kit at temperatures between 2 and 8C, protected from direct light, and under relative humidity conditions below 90%. Proper storage helps maintain reagent integrity and assay accuracy.
Q: What makes this chemiluminescent immunoassay preferable for T3 quantification?
A: The chemiluminescent immunoassay (CLIA) provides high sensitivity and specificity in the quantification of total T3. The ready-to-use format reduces errors, while automatic analyzer compatibility, stable calibration, and accurate measurement range collectively enhance laboratory efficiency and diagnostic reliability.
Q: How many tests can be performed with one Snibe MAGLUMI T3 reagent kit?
A: Each reagent kit is designed to conduct up to 100 individual T3 tests, making it highly suitable for medium to high-throughput clinical laboratories and diagnostic facilities.
Q: What are the primary benefits of using the Snibe MAGLUMI T3 (CLIA) kit for thyroid testing?
A: Primary benefits include high accuracy (within-run CV 10%), broad measurement range, minimal setup with ready-to-use reagents, long calibration stability, and compatibility with fully automatic MAGLUMI analyzers. These features ensure rapid, consistent, and precise T3 testing for clinical decisions.